Manufacturing · New Jersey, United States · 70,000 Employees
View Company Info for Free
$20.2B
Total Funding Amount
$5B
Most Recent Funding Amount
6
Number of Funding Rounds
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutica l segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.Read more
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Merck & Co has new funding data
Check if Merck & Co has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Merck & Co had a recent Job posting/layoffs
Check out if Merck & Co is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Merck & Co
Merck & Co, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Merck & Co launches new products
Earning: See what the market has to say on Merck & Co recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Analyze insights from companies similar to Merck & Co and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
More similar companies
How does Rob Davis compare against Competing Companies' CEOs?
Rob Davis
CEO at Merck & Co
CEO effectiveness to drive business results
VS.
CEO effectiveness to drive business results
Joaquin Duato
CEO at Johnson & Johnson Servi...
Oleg Khaykin
CEO at VIAVI
Albert Bourla
CEO at Pfizer
Merck & Co uses at least 5 email formats with first.last (ex. John.Smith@merck.com) being used 53.9% of the time
| Merck & Co Email Formats | Percentage | |
|---|---|---|
| first.last | John.Smith@merck.com | 53.9% |
| first_last | John_Smith@merck.com | 18.6% |
| first.last | John.Smith@merckgroup.com | 3.4% |
| last.first | Smith.John@merckgroup.com | 0.2% |
| first + last | JohnSmith@merck.com | |
Get Verified Emails
Gather financial insights about Merck & Co, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
View Merck & Co’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
A closer look at the technologies used by Merck & Co
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas,... Read More
